Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene delivery

The reversibility of neuropathic lysosomal storage diseases, including MPS IIIA, is a major goal in therapeutic development, due to typically late diagnoses and a large population of untreated patients. We used self-complementary adeno-associated virus (scAAV) serotype 9 vector expressing human N-su...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Haiyan, Cataldi, Marcela P, Ware, Tierra A, Zaraspe, Kimberly, Meadows, Aaron S, Murrey, Darren A, McCarty, Douglas M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898406/
https://www.ncbi.nlm.nih.gov/pubmed/27331076
http://dx.doi.org/10.1038/mtm.2016.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898406/
https://www.ncbi.nlm.nih.gov/pubmed/27331076
http://dx.doi.org/10.1038/mtm.2016.36

Ejemplares similares